` Comparison: BOLT vs ABBV - Alpha Spread

BOLT
vs
ABBV

Over the past 12 months, BOLT has underperformed ABBV, delivering a return of -48% compared to the ABBV's +14% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BOLT
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BOLT Intrinsic Value
0.35 USD
Overvaluation 93%
Intrinsic Value
Price
ABBV Intrinsic Value
219.81 USD
Fairly Valued
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Bolt Biotherapeutics Inc
NASDAQ:BOLT
5.08 USD
Abbvie Inc
NYSE:ABBV
220.35 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BOLT, ABBV

BOLT
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Bolt Biotherapeutics Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BOLT, ABBV

BOLT
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Bolt Biotherapeutics Inc
NASDAQ:BOLT
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BOLT
0%
ABBV
71.2%

Operating Margin

BOLT
-860.8%
ABBV
33.1%

Net Margin

BOLT
-821.6%
ABBV
3.9%

FCF Margin

BOLT
-908.5%
ABBV
33%

ROE

BOLT
-82%
ABBV
138.5%

ROA

BOLT
-48.9%
ABBV
1.7%

ROIC

BOLT
-104.4%
ABBV
28.4%

ROCE

BOLT
-61.1%
ABBV
20.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BOLT, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BOLT, ABBV

Loading
BOLT
ABBV
Difference
www.alphaspread.com

Performance By Year
BOLT, ABBV

Loading
BOLT
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BOLT to other stocks
PNEXF
Pharnext SCA
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
VRTX
Vertex Pharmaceuticals I...
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account